'Antimalarial drug' presentation slideshows

Chapter 28 Protista The Origins of Eukaryotic Diversity

Chapter 28 Protista The Origins of Eukaryotic Diversity. Overview Protista ; In the past, a single kingdom Note ; some closely related to P lants to Fungi or to Animals ( So kingdom Protista has been abandoned !!! and

767 views • 42 slides

The Citric Acid Cycle II and the Pentose Phosphate Pathway 4/22/2003

The Citric Acid Cycle II and the Pentose Phosphate Pathway 4/22/2003. The Citric acid cycle. Overall reaction. 3NAD+ + FAD + GDP + Pi + acetyl-CoA 3NADH + FADH + GTP + CoA + 2CO 2. Overview. 24 E2 subunits 24 E1 orange a and b together

532 views • 38 slides

Malaria Parasite Molecular and Drug Sensitivity Dynamics in Kenya

Malaria Parasite Molecular and Drug Sensitivity Dynamics in Kenya. Dr. Ben Andagalu Co-Director, Malaria Drug Resistance Laboratory, US Army Medical Research Directorate-Africa |KEMRI ben.andagalu@usamru-k.org. Disclaimer

315 views • 31 slides

Abdelkrim Smine, Ph.D. Global Assistance Initiatives Drug Quality and Information Program 12601 Twinbrook Parkway Rockvi

Antimalarial drug quality in Mekong countries. Abdelkrim Smine, Ph.D. Global Assistance Initiatives Drug Quality and Information Program 12601 Twinbrook Parkway Rockville, MD 20852. www.USPDQI.org. Supported by USAID. ICIUM 2004. Antimalarial drug quality in Mekong countries.

311 views • 18 slides

Prevention of malaria in pregnancy in Malawi

Prevention of malaria in pregnancy in Malawi. A successful collaboration between malaria control and reproductive health Peter Kazembe Allan Macheso Ministry of Health and Population Lilongwe MALAWI. Malawi in Africa. Blantyre. Malawi: Background data.

626 views • 17 slides

R1-R10 : Dr. Example Research

180 views • 2 slides

R1-R10 : Dr. Example Research

142 views • 2 slides